Role of Desumoylation in the Development of Prostate Cancer
Open Access
- 1 August 2006
- journal article
- review article
- Published by Elsevier BV in Neoplasia
- Vol. 8 (8), 667-676
- https://doi.org/10.1593/neo.06445
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Nucleocytoplasmic Shuttling Modulates Activity and Ubiquitination-Dependent Turnover of SUMO-Specific Protease 2Molecular and Cellular Biology, 2006
- Down-Regulation of c-Fos/c-Jun AP-1 Dimer Activity by SumoylationMolecular and Cellular Biology, 2005
- SENP1 Enhances Androgen Receptor-Dependent Transcription through Desumoylation of Histone Deacetylase 1Molecular and Cellular Biology, 2004
- The Polycomb Protein Pc2 Is a SUMO E3Cell, 2003
- Pathological and molecular aspects of prostate cancerThe Lancet, 2003
- Androgen receptor expression in androgen‐independent prostate cancer cell linesThe Prostate, 2001
- Regulation of Pax3 transcriptional activity by SUMO-1-modified PMLOncogene, 2001
- TUMOR NECROSIS FACTOR-α REPRESSES ANDROGEN SENSITIVITY IN THE LNCaP PROSTATE CANCER CELL LINEJournal of Urology, 2000
- Covalent Modification of PML by the Sentrin Family of Ubiquitin-like ProteinsOnline Journal of Public Health Informatics, 1998
- An Essential Yeast Gene Encoding a Homolog of Ubiquitin-activating EnzymeOnline Journal of Public Health Informatics, 1995